Whittemore Tingley - Aug 16, 2023 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role
Chief Medical Officer
Signature
/s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Stock symbol
TNYA
Transactions as of
Aug 16, 2023
Transactions value $
-$21,195
Form type
4
Date filed
8/18/2023, 06:33 PM
Previous filing
Feb 17, 2023
Next filing
Feb 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNYA Common Stock Sale -$21.2K -5.56K -6.78% $3.81 76.4K Aug 16, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023.
F2 Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.76 to $3.87. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 Includes 64,375 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 2,000 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on June 10, 2023.